COVID-19 vaccine maker Novavax <a href="https://www.reuters.com/markets/companies/NVAX.O" target="_blank">(NVAX.O)</a> on Thursday beat market estimates for quarterly revenue, boosted by U.S. government grants to help cover the expense of clinical trials, and…